China Medical System Holdings Ltd

Common Name
China Medical System Holdings
Country
Hong Kong
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
6,095
Ticker
867
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company offers cardio-ce...

China Medical System Holdings's GHG Emissions Data Preview

In 2023, China Medical System Holdings completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, China Medical System Holdings has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
b
0000000
Download Data

Verified Sources Behind China Medical System Holdings’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore China Medical System Holdings’s data sources below and access millions more through our Disclosure Search.

a. China Medical System Holdings's ESG Report 2023
a. China Medical System Holdings's ESG Report 2023
b. China Medical System Holdings's ESG Report 2022
b. China Medical System Holdings's ESG Report 2022

Insights into China Medical System Holdings's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of China Medical System Holdings amounted to 5,759.4 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of China Medical System Holdings decreased by 41.6%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a b

China Medical System Holdings's Scope 1 Emissions Over Time

202020212022202301.5 k3 k4.5 k6 ktCO2e-6%-3%-70%
  • Total Scope 1
  • Year-over-Year Change

What are China Medical System Holdings's Scope 1 emissions?

In 2023, the total Scope 1 emissions of China Medical System Holdings were 1,628.4 metric tons of CO₂ equivalent (tCO₂e). a

Has China Medical System Holdings reduced its Scope 1 emissions over time?

Since 2020, China Medical System Holdings's Scope 1 emissions have decreased by 72.38%, reflecting a declining long-term trend in Scope 1 emissions over time. a

Compared to the previous year (2022), China Medical System Holdings's Scope 1 emissions decreased by 69.8%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a b

What are China Medical System Holdings's Scope 2 emissions?

In 2023, China Medical System Holdings reported Scope 2 greenhouse gas (GHG) emissions of 4,131 tCO₂e without specifying the calculation method. a

Has China Medical System Holdings reduced its Scope 2 emissions over time?

Since 2020, China Medical System Holdings's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have decreased by 38.22%, reflecting a declining long-term trend in Scope 2 emissions over time. a

Compared to the previous year (2022), China Medical System Holdings's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that China Medical System Holdings 's emissions have plateaued with no significant change in its energy consumption footprint. a b

What methodology does China Medical System Holdings use for Scope 2 reporting?

In 2023, China Medical System Holdings reported its Scope 2 emissions using an unspecified methodology. a

China Medical System Holdings's Scope 2 Emissions Over Time

202020212022202302 k4 k6 k8 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into China Medical System Holdings’s GHG Emissions Intensity Compared to Industry Peers

In 2023, China Medical System Holdings reported Scope 1 greenhouse gas (GHG) emissions of 1,628.4 tCO₂e and total revenues of USD 1,233 millions. This translates into an emissions intensity of 1.32 tCO₂e per millions USD. a

China Medical System Holdings's Scope 1 Emissions Intensity Compared to Peers

505005,00050,000500,000Scope 1 Emissions (tCO2e)505002,00020,000100,000Revenues (Millions of USD)CPCNDJCCCR PharmaYear: 2024Scope 1: 175,023 tCO2eRevenue: $M 38,435Scope 1 Intensity: 4.55 tCO2e/$MAjanta PharmaYear: 2025Scope 1: 6,392 tCO2eRevenue: $M 537Scope 1 Intensity: 11.90 tCO2e/$MFagronYear: 2023Scope 1: 4,218 tCO2eRevenue: $M 844Scope 1 Intensity: 4.99 tCO2e/$MTong Ren TangYear: 2023Scope 1: 116 tCO2eRevenue: $M 195Scope 1 Intensity: 0.59 tCO2e/$MPPPorton Pharma SolutionsYear: 2024Scope 1: 18,865 tCO2eRevenue: $M 413Scope 1 Intensity: 45.71 tCO2e/$MHUTCHMED (China)Year: 2024Scope 1: 3,083 tCO2eRevenue: $M 4,926Scope 1 Intensity: 0.63 tCO2e/$MBioKangtaiYear: 2023Scope 1: 15,952 tCO2eRevenue: $M 489Scope 1 Intensity: 32.60 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2023Scope 1: 48,815 tCO2eRevenue: $M 777Scope 1 Intensity: 62.81 tCO2e/$MLaboratorios Farmaceuticos ROVIYear: 2024Scope 1: 9,566 tCO2eRevenue: $M 795Scope 1 Intensity: 12.04 tCO2e/$MConsun Pharmaceutical GroupYear: 2023Scope 1: 54,210 tCO2eRevenue: $M 398Scope 1 Intensity: 136.27 tCO2e/$MEvotecYear: 2024Scope 1: 13,756 tCO2eRevenue: $M 829Scope 1 Intensity: 16.59 tCO2e/$MJB PharmaYear: 2025Scope 1: 5,652 tCO2eRevenue: $M 452Scope 1 Intensity: 12.50 tCO2e/$MNatco PharmaYear: 2025Scope 1: 28,495 tCO2eRevenue: $M 518Scope 1 Intensity: 54.96 tCO2e/$MCCChina TCMYear: 2024Scope 1: 104,425 tCO2eRevenue: $M 2,474Scope 1 Intensity: 42.21 tCO2e/$MNNNippon ShinyakuYear: 2023Scope 1: 4,366 tCO2eRevenue: $M 1,082Scope 1 Intensity: 4.03 tCO2e/$MGland PharmaYear: 2025Scope 1: 13,920 tCO2eRevenue: $M 654Scope 1 Intensity: 21.30 tCO2e/$MLotus PharmaceuticalYear: 2024Scope 1: 2,672 tCO2eRevenue: $M 567Scope 1 Intensity: 4.71 tCO2e/$MHepalinkYear: 2024Scope 1: 18,284 tCO2eRevenue: $M 724Scope 1 Intensity: 25.27 tCO2e/$MDDDa Ren TangYear: 2023Scope 1: 5,902 tCO2eRevenue: $M 1,157Scope 1 Intensity: 5.10 tCO2e/$MJamjoom Pharmaceuticals FactoryYear: 2024Scope 1: 7,248 tCO2eRevenue: $M 351Scope 1 Intensity: 20.65 tCO2e/$MPiramal PharmaYear: 2025Scope 1: 61,351 tCO2eRevenue: $M 1,061Scope 1 Intensity: 57.85 tCO2e/$MIPCA LaboratoriesYear: 2025Scope 1: 169,992 tCO2eRevenue: $M 1,036Scope 1 Intensity: 164.03 tCO2e/$MJJJubilant PharmovaYear: 2025Scope 1: 10,084 tCO2eRevenue: $M 842Scope 1 Intensity: 11.98 tCO2e/$MSumitomo PharmaYear: 2023Scope 1: 27,093 tCO2eRevenue: $M 4,171Scope 1 Intensity: 6.50 tCO2e/$MChina Medical System HoldingsYear: 2023Scope 1: 1,628 tCO2eRevenue: $M 1,233Scope 1 Intensity: 1.32 tCO2e/$M

How does China Medical System Holdings's GHG emissions intensity compare to its peers?

In 2023, China Medical System Holdings reported a Scope 1 emissions intensity of 1.32 tCO₂e per millions USD. Compared to the peer group median of 14.55 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does China Medical System Holdings rank on GHG emissions intensity within its industry?

In 2023, China Medical System Holdings ranked 3 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places China Medical System Holdings among the top performers, with one of the lowest emissions intensities relative to peers. a

Want Full Access to China Medical System Holdings's GHG Emissions Dataset?
Sign Up